Ophth Production Facility

Blindness, a major health problem, has received relatively little attention in under-developed countries where the vast majority of the world’s blind live. Infections, malnutrition and lack of eye care give rise to high proportion of blindness. Of an estimated 30 million blind in the world (blindness defined as inability to count fingers at a distance of three meters (3/60), 6 million live in Africa, 20 million in Asia and about 2 million in Latin America, contributing in total 90% of world’s blindness’. A study shows that About 2 million people are blind in Pakistan -estimated Pakistan’s population is 120 million. Various conditions responsible for blindness are: Cataract 66.7% (1.33 million), Corneal opacity 12.6% (0.25 million), Refractive errors 11.4% (0.23 million), Glaucoma 3.9% (0.08 million), other causes 5.4% (0.11 million).

Estimated prevalence of blindness in Pakistan varies from 2.0% to 4.3%. Prevention and control of eye diseases is the main area to fight against blindness. Although In time and accurate diagnosis is the first & important step but provision and availability of quality and economic pharmaceutical product is the main weapon to fight with.

Alza Pharmaceuticals started operation in 1997 with the commitment to infuse vision into the people and turn the idle hands of the society to working hands. Sterile manufacturing environment is the key to produce quality ophthalmic products. Alza Pharma maintains a strict aseptic environment conforming to the WHO cGMP guidelines and other international regulatory requirements. Alza is proud to having an international standard sterile manufacturing zone and backup utilities with fully automated machineries. The facilities include laminar air flow module, microbial monitoring device, automatic cleaning machine, automatic filling machine, double door autoclave for sterilization, continuous data monitoring device etc. Most importantly it has a state-of-the-art plant for WFI, the injectable grade water since most of the eye formulations require quality of water that can only be made by this type of special & high tech WFI plant of European origin.

Alza Pharmaceuticals as a specialized in ophthalmology, has the facility to manufacture all types of ophthalmic eye drops for treating ocular infections, inflammation, allergy, dry eye, glaucoma, age related macular degeneration and other eye diseases and disorders.